Drug Research
BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors...
Drug Research
Lonza Completes Expansion of Conjugation Facility in Visp
Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland.
The expansion includes two...
Drug Research
HPAPI Worldwide Market Is Booming – To Stay Today, Forever
As per a market report by Reportlinker, the worldwide highly potent active pharmaceutical ingredient- HPAPI sector is anticipated to breach the $34.04 billion mark by...
Drug Research
Cancer Vaccine Redesign – A Transformation In The Making
Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The researchers...
Drug Research
RMAT Status Given To Cardiac Gene Therapy – A First From FDA
The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes to the treatment of Danon...
Drug Research
Evotec, Related Sciences expand integrated drug discovery and development partnership
Evotec SE announced that the company has extended and expanded its integrated multi-target drug discovery agreement with data-driven biotech creation firm, Related Sciences (RS), to...
Drug Research
BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
BD, a leading global medical technology company, announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.